Pediatrics News and Research

Latest Pediatrics News and Research

ADA promotes Indian health service funding options before Congress

The American Dental Association (ADA) looks forward to working with Congress in continuing to reduce oral health disease in Indian country, said Dr. Jerry Long, chairman of the ADA's Council on Government Affairs.

20 Apr 2007

Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma

Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).

20 Apr 2007

Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

A new review suggests that asthma treatment based on tests of fluid coughed up from the lungs could reduce the frequency and severity of flare-ups in adult asthma patients.

19 Apr 2007

Preschool children in rural areas eat more fruits and vegetables when the produce is homegrown

If you are looking for a way to encourage your children eat their fruits and vegetables, search no further than your backyard, suggests new Saint Louis University research.

19 Apr 2007

Laparoscopic dismembered pyeloplasty in children younger than 2 years

Laparoscopy has been implemented in the pediatric urologic population for many different operative interventions.

19 Apr 2007

Review of all major studies involving anti-depressants in children

Today, the Journal of the American Medical Association (JAMA) published a review of all major studies involving anti-depressants in children and adolescents by a team of researchers from Western Psychiatric Institute in Pittsburgh.

18 Apr 2007

New study to assess bariatric surgery in extremely overweight teens

The National Institutes of Health (NIH) has launched an observational study to evaluate the benefits and risks of bariatric surgery in adolescents.

18 Apr 2007

Risks and benefits of antidepressant treatment for children with depression

According to a new study, conducted by the Center for Innovation in Pediatric Practice (CIPP) at Columbus Children's Hospital and published in the April 18 issue of The Journal of the American Medical Association (JAMA), there is more information for parents about the risks and benefits of antidepressant treatment for children with depression and anxiety disorders.

18 Apr 2007

Benefits of antidepressants for children and teens with depression or anxiety disorders may outweigh risks

A review of previous studies indicates that the benefits of antidepressants for children and teens with depression or anxiety disorders may outweigh their risks, and that the increased risk for suicidal thoughts and attempts from using these medications is not statistically significant, according to an article in the April 18 issue of JAMA.

18 Apr 2007

Antidepressants safe for children and adolescents - black box warnings questioned

Antidepressants are safe and effective for treating anxiety, obsessive compulsive disorder (OCD) and major depressive disorder in children and adolescents, according to a meta-analysis of 27 major studies.

18 Apr 2007

Silver Award for advances in the prevention of HIV perinatal transmission

The Children's Hospital of Philadelphia presented J. Brooks Jackson, M.D., MBA, of Johns Hopkins University with the Herman and Gertrude Silver Award for his internationally prominent work in preventing the transmission of HIV from infected mothers to their newborn babies.

17 Apr 2007

Johns Hopkins to test all children for 'superbugs'

Infection control and critical care experts at The Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit.

17 Apr 2007

Bullying widespread in elementary students

Nine out of 10 elementary students have been bullied by their peers, according to a simple questionnaire developed by researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.

15 Apr 2007

Lupin Pharmaceuticals receives FDA approval for Suprax

Lupin Pharmaceuticals has announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for Suprax (Cefixime for oral suspension 200mg/5ml).

15 Apr 2007

Asthma can lead to psychosocial disadvantages for children in our society

Much of the research surrounding childhood asthma has sought new approaches to managing the disease.

15 Apr 2007

FDA approves GlaxoSmithKline's antibacterial Altabax

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.

14 Apr 2007

Aflac expands partnership with American Association for Cancer Research

Recognizing the growing need to nurture the next generation of cancer researchers, Aflac has expanded its generous commitment to the American Association for Cancer Research by sponsoring the new AACR-Aflac Career Development Award for Pediatric Cancer Research, in addition to renewing its support for the AACR Associate Member Council and the AACR-Aflac Scholar-in-Training Awards, now in their 10th year.

11 Apr 2007

U.S. District Court grants Mylan extension for consideration of Amlodipine Besylate exclusivity

Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).

11 Apr 2007

Rising vaccine costs put kids at risk

The American Academy of Pediatrics (AAP) is alarmed that the soaring costs of vaccines combined with lower reimbursements from insurance companies will lead to the under- immunization of the nation's children and unnecessary outbreaks of preventable diseases.

11 Apr 2007

Novalar Pharmaceuticals submits NDA for dental anesthetic reversal agent

Novalar Pharmaceuticals, Inc. today announced the submission of a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) for marketing approval of NV-101, a local dental anesthetic reversal agent.

11 Apr 2007